Menu

ISTOCK, SEZERYADIGAR

Arrests, Investigations Over Vaccine Scandal in China

Changsheng is found to have forged records for a rabies vaccine and is accused of distributing thousands of substandard DPT immunizations to be used in children.

Jul 27, 2018
Kerry Grens

Vaccine maker Changsheng fudged documentation on the quality of materials used in its rabies vaccine and violated the law, a Chinese government investigation has found. The conclusion comes as 15 people, including the chair of the company, are arrested on “suspicion of criminal offences,” Al Jazeera reports.

“The company used expired materials to produce some rabies vaccine and falsified the production date,” according to a government investigation cited by Reuters. “To cover up violations, the company systematically fabricated production and testing records.”

The fallout from the falsified records on the rabies vaccines comes amid news about another serious lapse by Changsheng in which it allegedly sold more than 250,000 doses of an ineffective diphtheria, pertussis, and tetanus (DPT) vaccine.

Problems emerged with Changsheng’s products last year, when China’s regulatory authority found the DPT vaccine to be subpar. Then this summer, Changsheng voluntarily recalled its rabies vaccine after admitting to falsifying records.

Together, the scandals have sown distrust among parents. “We always say that kids are the nation’s future, but if we can’t ensure the safety of such a future, what does the future hold for us?” Huo Xiaoling, whose 1-year-old daughter received a vaccine made by Changsheng, tells The New York Times. She adds that she won’t buy any more Chinese-made vaccines.

The Times notes that there is no evidence anyone has been hurt by the DPT vaccines.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.